Shang Hai Zheng Quan Bao·2026-02-27 21:23Core Viewpoint - The company held its first extraordinary general meeting of shareholders in 2026, where a significant resolution regarding the spin-off of its subsidiary, Fosun Antigen, was discussed. The proposal to provide guaranteed allocations to A-shareholders was rejected, but the spin-off plan remains unaffected [2][10]. Meeting Details - The extraordinary general meeting was held on February 27, 2026, at Shanghai Tianxi Jiafu Puti Hotel [3]. - The total number of shares with voting rights was 2,639,554,073, including 2,098,582,573 A-shares and 540,971,500 H-shares [3]. Voting Results - The proposal to spin off Fosun Antigen to the Hong Kong Stock Exchange was approved in the general meeting, while the specific proposal to provide guaranteed allocations to A-shareholders was not approved in the A-share meeting [7][9]. - The resolutions regarding the spin-off were passed in the H-share meeting, indicating a split in shareholder support between A and H shareholders [10]. Legal Compliance - The meeting was conducted in accordance with the Company Law of the People's Republic of China and the company's articles of association, ensuring the legality of the proceedings and voting [4][11].